Cargando…
Synergy between CD8 T Cells and Th1 or Th2 Polarised CD4 T Cells for Adoptive Immunotherapy of Brain Tumours
The feasibility of cancer immunotherapy mediated by T lymphocytes is now a clinical reality. Indeed, many tumour associated antigens have been identified for cytotoxic CD8 T cells, which are believed to be key mediators of tumour rejection. However, for aggressive malignancies in specialised anatomi...
Autores principales: | Hoepner, Sabine, Loh, Jacelyn M. S., Riccadonna, Cristina, Derouazi, Madiha, Maroun, Céline Yacoub, Dietrich, Pierre-Yves, Walker, Paul R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662716/ https://www.ncbi.nlm.nih.gov/pubmed/23717511 http://dx.doi.org/10.1371/journal.pone.0063933 |
Ejemplares similares
-
Adoptive immunotherapy for AML with CD123-engager T cells
por: Bonifant, Challice, et al.
Publicado: (2015) -
CTLA-4 Engagement Inhibits Th2 but not Th1 Cell Polarisation
por: Ubaldi, Vanessa, et al.
Publicado: (2003) -
Cell-penetrating peptides—the Swiss Army knife of cancer vaccines
por: Walker, Paul R., et al.
Publicado: (2015) -
Adoptive tumour immunotherapy using human CD4+ T-cells.
por: Gold, J. E., et al.
Publicado: (1993) -
Experimental observation of the effect of immunotherapy on CD4+ T cells and Th1/Th2 cytokines in mice with allergic rhinitis
por: Zhu, Yu, et al.
Publicado: (2023)